"A major hurdle in taking vaccines and other biologics from discovery and preclinical development to the market is the development of an economically viable process for manufacturing at an industrial scale. Recent advances in manufacturing processes for protein-based vaccines and therapeutics have provided a much greater choice of potential production systems than was available even five years ago, including novel bacterial, yeast, fungal, plant and insect- or animal-cell systems. This session will focus on several different expression systems and consider the advantages that each can bring to large-scale protein production."

Objective1:Review recent advances in protein expression and production at an industrial scale.

Objective2:"Provide an appreciation of the diversity of technologies available for the expression and production of proteins at an industrial scale and of their suitability for particular applications."

Objective3:Compare and contrast different protein expression and production systems and consider the advantages these can bring to large-scale protein production.